Kimberly-Clark to Acquire Tylenol Maker Kenvue in Over 40 Billion Dollar Deal
Kimberly-Clark has announced plans to acquire Kenvue, the company behind Tylenol and other well-known consumer health brands, in a cash-and-stock transaction valued at approximately 48.7 billion dollars.
Kimberly-Clark To Acquire Tylenol Maker | 04/11/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy